No abstract available
Publication types
-
Comment
-
Comparative Study
-
Letter
MeSH terms
-
Administration, Oral
-
Bone Density Conservation Agents / adverse effects*
-
Bone Density Conservation Agents / therapeutic use
-
Calcitonin / therapeutic use
-
Diphosphonates / adverse effects*
-
Esophageal Neoplasms / chemically induced
-
Esophageal Neoplasms / epidemiology*
-
Humans
-
Incidence
-
Osteoporosis / drug therapy
-
Raloxifene Hydrochloride / therapeutic use
-
SEER Program
-
United States / epidemiology
Substances
-
Bone Density Conservation Agents
-
Diphosphonates
-
Raloxifene Hydrochloride
-
Calcitonin